Tag: LOTIS-2

Durable responses for loncastuximab tesirine in relapsed/refractory DLBCL

Presented By
Dr Paolo Caimi, Cleveland Clinic, Ohio, USA
Trial
Phase 2, LOTIS-2
Conference
EHA 2023
Type
Peer-reviewed article

2 August 2023 16:12

Promising chemo-free treatment options in r/r DLBCL

Presented By
Prof. Marco Ladetto, University del Piemonte Orientale, Italy
Trial
LOTIS-2
Conference
EHA 2021
Type
Peer-reviewed article

5 August 2021 11:17
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com